Allegiant Travel Co (NASDAQ: ALGT) stock closed at $83.93 on 2/5/25 after a major decline of -15.3%. Moreover, this decline was accompanied by exceptionally high trading volume at 369% of normal. The stock has declined […]
Extremely significant negative changes in San Juan Basin Royalty Trust (NYSE: SJT) investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, and its shorter term price trend turned down. […]
Recent notable negative changes in fundamentals have affected Oxford Industries Inc. (NYSE: OXM): the consensus estimate for January, 2024 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for January, 2025 decreased significantly. […]
On 2/5/25, NOV Inc (NYSE: NOV) stock enjoyed a major increase of 12.7%, closing at $16.43. Moreover, this advance was accompanied by exceptionally high trading volume at 313% of normal. The stock has been weak […]
Mercury Systems Inc (NASDAQ: MRCY) stock enjoyed a major increase of 18.5% on 2/5/25. The shares closed at $49.88. Moreover, exceptionally high trading volume at 626% of normal accompanied the advance. The stock has been […]
Embraer SA (NYSE: ERJ) stock enjoyed a major increase of 14.8% on 2/5/25. The shares closed at $45.76. Moreover, trading volume in this advance was exceptionally high at 365% of normal. The stock has risen […]
Banco Santander Brasil SA (NYSE: BSBR) has benefited from exceptional positive changes in investment behavior: positive upside/downside volume developed, its shorter term price trend turned up, and the stock rose on very heavy volume. Recent […]
ATI Inc (NYSE: ATI) has reported E.P.S. of $0.97 for its fourth fiscal quarter (ending December 31) versus $1.15 for the same period a year ago — a decline of -16%. For the latest four […]
For its fourth fiscal quarter (ending December 31), AMETEK Inc (NYSE: AME) has reported a 13% increase in E.P.S. from $1.49 a year ago to $1.68 in the current quarter. For the latest four quarters […]
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has reported E.P.S. of $8.53 for its fourth fiscal quarter (ending December 31) versus $10.88 for the same period a year ago — a decline of -22%. For the latest […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research